Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
E
352940
vs
K
KOSPI 200
Over the past 12 months, EnBio Co Ltd has underperformed KOSPI 200, delivering a return of -16% compared to KOSPI 200's +65% growth.
Stocks Performance
352940 vs KOSPI 200
Performance Gap
352940 vs KOSPI 200
Performance By Year
352940 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
EnBio Co Ltd
Glance View
EnBio Co Ltd makes medical testing products, mainly diagnostic reagents and kits used in laboratories and healthcare settings. Its products help detect diseases or measure biological markers, so the company sits on the tools-and-supplies side of the healthcare value chain rather than inside direct patient care. The company sells to hospitals, clinics, diagnostic labs, and distributors that serve those customers. It makes money by manufacturing and selling these test kits and related consumables, which can create repeat business because labs need to keep buying supplies to run tests. What makes this kind of business different is that its value depends on the reliability and accuracy of its assays, not on brand-name consumer demand. Once a test is adopted by a lab or medical channel, the company can benefit from steady follow-on sales of the same reagents and kits over time.